Kura Oncology Inc (NASDAQ: KURA) is -9.18% lower on its value in year-to-date trading and has touched a low of $6.98 and a high of $24.17 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The KURA stock was last observed hovering at around $8.03 in the last trading session, with the day’s loss setting it -0.12%.
Currently trading at $7.91, the stock is 1.33% and -16.44% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.36 million and changing -1.49% at the moment leaves the stock -54.09% off its SMA200. KURA registered -62.06% loss for a year compared to 6-month loss of -61.99%. The firm has a 50-day simple moving average (SMA 50) of $9.4665 and a 200-day simple moving average (SMA200) of $17.22795.
The stock witnessed a -7.05% gain in the last 1 month and extending the period to 3 months gives it a -54.44%, and is -0.88% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.07% over the week and 4.84% over the month.
Kura Oncology Inc (KURA) has around 142 employees, a market worth around $615.11M and $0.00M in sales. Distance from 52-week low is 13.32% and -67.27% from its 52-week high. The company has generated returns on investments over the last 12 months (-45.21%).
with sales reaching $57.96M over the same period.The EPS is expected to shrink by -14.67% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Kura Oncology Inc (KURA) Top Institutional Holders
257.0 institutions hold shares in Kura Oncology Inc (KURA), with institutional investors hold 115.31% of the company’s shares. The shares outstanding are 77.75M, and float is at 65.24M with Short Float at 12.48%. Institutions hold 114.00% of the Float.
The top institutional shareholder in the company is SUVRETTA CAPITAL MANAGEMENT, LLC with over 7.07 million shares valued at $145.56 million. The investor’s holdings represent 8.4258% of the KURA Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 6.97 million shares valued at $143.43 million to account for 8.302 of the shares outstanding. The other top investors are ECOR1 CAPITAL, LLC which holds 5.81 million shares representing 6.9208% and valued at over $119.56 million, while DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) holds 6.4496 of the shares totaling 5.41 million with a market value of $111.42 million.
Kura Oncology Inc (KURA) Insider Activity
The most recent transaction is an insider sale by DOYLE THOMAS JAMES, the company’s SVP, Finance & Accounting. SEC filings show that DOYLE THOMAS JAMES sold 4,949 shares of the company’s common stock on Jan 28 ’25 at a price of $7.87 per share for a total of $38958.0. Following the sale, the insider now owns 88193.0 shares.
Kura Oncology Inc disclosed in a document filed with the SEC on Jan 28 ’25 that Leoni Mollie (Chief Medical Officer) sold a total of 4,963 shares of the company’s common stock. The trade occurred on Jan 28 ’25 and was made at $7.87 per share for $39068.0. Following the transaction, the insider now directly holds 88253.0 shares of the KURA stock.
Still, SEC filings show that on Jan 28 ’25, Bair Teresa Brophy (Chief Legal Officer) disposed off 7,281 shares at an average price of $7.87 for $57315.0. The insider now directly holds 107,948 shares of Kura Oncology Inc (KURA).
